## Chronic Rhinosinusitis: Polyp vs. Non-Polyp Phenotypes ### Pathophysiological and Clinical Distinctions | Feature | CRSwNP (With Polyps) | CRSsNP (Without Polyps) | |---------|---------------------|------------------------| | **Gross appearance** | Bilateral, pale, gelatinous masses | Mucosal edema, no discrete masses | | **Inflammation type** | Eosinophil-predominant (Type 2) | Mixed neutrophilic/eosinophilic (Type 1/3) | | **Serum IgE** | Often elevated | Normal to mildly elevated | | **Allergy association** | Frequent (aspirin sensitivity, asthma) | Less common | | **Asthma prevalence** | 40–60% | 10–20% | | **Response to steroids** | Excellent | Moderate | | **Recurrence rate** | High (20–30% after surgery) | Lower | | **Bone erosion** | Rare | More common | **Key Point:** CRSwNP is fundamentally a **Type 2 immune-mediated (eosinophilic) disease**, whereas CRSsNP is predominantly **Type 1/3 (neutrophilic/mixed) inflammation**. This immunological difference is the core discriminator. ### Histopathology **CRSwNP:** - Eosinophilic infiltration (>10 eosinophils per high-power field) - Basement membrane thickening - Stromal edema - Minimal glandular involvement **CRSsNP:** - Neutrophilic infiltration predominates - Fibrosis and glandular hyperplasia - Bacterial biofilm formation (more common) - Bone remodeling and erosion (more frequent) **Clinical Pearl:** A patient with CRSwNP who also has asthma and aspirin sensitivity represents the **Samter's triad** variant — a high-yield association for NEET PG. These patients respond exceptionally well to topical and systemic corticosteroids. **High-Yield:** The **eosinophilic phenotype** (elevated serum IgE, eosinophil-rich tissue, Type 2 cytokine profile) is the single best discriminator of CRSwNP and predicts steroid responsiveness and surgical recurrence risk. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.